WAVE Life Sciences (WVE) Misses Q2 EPS by 4c

WAVE Life Sciences (NASDAQ: WVE) reported Q2 EPS of ($0.31), $0.04 worse than the analyst estimate of ($0.27). Revenue for the quarter came in at $8.7 million versus the consensus estimate of $14.31 million.

For earnings history and earnings-related data on WAVE Life Sciences (WVE) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• AIG (AIG) on Watch Following Unconfirmed M&A Chatter
• Visteon (VC) 354 contracts of June 120 calls as share price up 6%